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During spinal cord development, astrocyte precur-
sors arise from neuroepithelial progenitors, delami-
nate from the ventricular zone, and migrate toward
their final locations where they differentiate.
Although the mechanisms underlying their early
specification and late differentiation are being deci-
phered, less is known about the temporal control of
their migration. Here, we show that the epithelial-
mesenchymal transition regulator Zeb1 is expressed
in glial precursors and report that loss of Zeb1
function specifically delays the onset of astrocyte
precursor delamination from the ventricular zone,
correlating with transient deregulation of the adhe-
sion protein Cadherin-1. Consequently, astrocyte
precursor invasion into the Zeb1/ mutant white
matter is delayed, and induction of their differentia-
tion is postponed. These findings illustrate how fine
regulation of adhesive properties influences the
onset of neural precursor migration and further sup-
port the notion that duration of exposure of migrating
astrocyte precursors to environmental cues and/or
their correct positioning influence the timing of their
differentiation.
INTRODUCTION
Oligodendrocytes and astrocytes constitute the main glial cell
populations of neural origin within the CNS. During embryogen-
esis, glial precursors arise from neural stem cells located in the
ventricular zone (VZ), after a primary phase of neurogenesis,Cell Repo
This is an open access article under the CC BY-Ndelaminate and migrate toward their final locations where they
differentiate. In the developing spinal cord, oligodendrocyte pre-
cursors (OPs) are generated from specific progenitor domains
along the dorsoventral (DV) axis, while astrocyte precursors
(APs) are produced from all progenitor domains in a ventral-to-
dorsal temporal sequence (Rowitch and Kriegstein, 2010; Tripa-
thi et al., 2011; Tien et al., 2012). The molecular mechanisms
controlling the gliogenic switch are beginning to be deciphered
and involve the Sox9 transcription factor that acts upstream of
NFIa to coordinate the arrest of neurogenesis and initiation of
gliogenesis (Stolt et al., 2003; Deneen et al., 2006; Kang et al.,
2012). Also, extensive studies have identified several key
signaling pathways and transcriptional regulators controlling
OP and AP differentiation (Kessaris et al., 2008; Rowitch and
Kriegstein, 2010; Emery and Lu, 2015).
In contrast, relatively less is known about the time window
during which newly specified OPs and APs have to exit the VZ
and invade the mantle zone (MZ). Zeb1 and Zeb2 form a small
family of transcription factors involved in many developmental
and physiopathological processes, including epithelial-mesen-
chymal transitions (EMTs) and the formation of neural crest-
derived tissues (Van de Putte et al., 2003; Gheldof et al., 2012;
Rogers et al., 2013; Ohayon et al., 2015). Recent findings have
established that Zeb2 controls OP maturation around birth
(Weng et al., 2012). Here we show that Zeb1 is expressed in em-
bryonic glial precursors and report its implication in the temporal
control of AP migration.
RESULTS AND DISCUSSION
Zeb1 and Zeb2 Exhibit Dynamic Expression Profiles in
the Mouse Developing Spinal Cord
During the neurogenic phase of the developing spinal cord, be-
tween embryonic days (E)9.5 and 12.5, we observed increasingrts 17, 1473–1481, November 1, 2016 ª 2016 The Author(s). 1473
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
levels of Zeb1 in VZ progenitors (Figures 1A, 1B, and 1J) that also
expressed Zeb2 at these stages (Figures S1A–S1C and 1J). In
the MZ, whereas Zeb2 wasmaintained in discrete neuronal pop-
ulations (Figures S1C–S1E and 1J), Zeb1 was gradually downre-
gulated in post-mitotic neurons, except in motoneurons (MNs;
Figures 1B, 1C, 1F, and 1J). During the gliogenic phase, Zeb1
was maintained in VZ progenitors (Figures 1C–1E and 1J), while
Zeb2 was downregulated from E12.5 and became undetectable
in these cells by E13.5 (Figures S1C, S1D, and 1J). At E13.5,
Zeb1-positive (+) cells were observed in the ventral MZ (Figures
1C and S1J), and their number increased subsequently with a
spatial distribution reminiscent of glial precursors (Figures 1D,
1E, and S1K). At E18.5, we confirmed that Zeb1 was largely
excluded from NeuN+ neuronal populations except in MNs (Fig-
ure 1F), but it was detected in Olig2+ OPs (Figures 1E, 1G, and
1J) and GFAP+ APs (Figures 1E, 1H, 1I, and 1J). In contrast,
Zeb2 was excluded frommigrating OPs and APs at early stages,
but it was selectively induced in OPs from E16.5 (Figures S1F,
S1G, and 1J; Weng et al., 2012).
At adulthood, Zeb1 was maintained in a small fraction of
Sox10+ and Olig2+ cells (Figures 1K and 1L) that were negative
for the mature oligodendrocyte marker CC1 (Figure 1M), indi-
cating that they were adult OPs. Moreover, co-expression of
Zeb1 with AldoC and GFAP (Figures 1N and 1O) showed that
mature astrocytes maintained Zeb1. A similar pattern of Zeb1
was observed in the adult cortex (Figures S1L and S1M). Alto-
gether, these data show the following: (1) during neurogenesis,
spinal cord VZ progenitors express both Zeb2 and Zeb1, albeit
at low levels, while only Zeb1 is robustly expressed in these cells
during gliogenesis; (2) Zeb1 is maintained in migrating OPs and
APs throughout embryogenesis; and (3) Zeb1 constitutes a spe-
cific marker for adult OPs and mature astrocytes.
Spinal Cord APs Are Selectively Affected in Zeb1/
Mutants
These observations prompted us to assess glial cell formation in
Zeb1/ animals (Takagi et al., 1998; see Figures S1N–S1Q) by
mainly focusing on the spinal cord. First, analysis of the spatio-
temporal expression profile of OP determinants, including
Olig2, Sox10, PDGFra, and PLP1 between E12.5 and E18.5,
showed that Zeb1 is dispensable for the earliest phases of OP
formation (Figures S2A–S2Q). In contrast, time course analysis
of Fgfr3 expression (Pringle et al., 2003) revealed a specific
requirement for Zeb1 in APs. Indeed, in wild-type (WT) embryos,
migrating Fgfr3+ APs in theMZ normally emerged in a ventral-to-
dorsal sequence starting at E13.5, and they expanded to popu-
late the entire width of the spinal cord by E18.5 (Figures 2A, 2C,
2E, 2G, 2I, and 2K; Tien et al., 2012). Strikingly, at E13.5, virtually
no Fgfr3+ AP was detected in the MZ of Zeb1/ embryos (Fig-
ure 2B). At E14.5, a fewmigrating APs were visualized, though at
locations and in numbers reminiscent ofWT at E13.5 (Figures 2A,
2D, 2M, and 2N). Also at E15.5, E16.5, and E17.5, the pattern of
Fgfr3+ cells in the mutant MZ resembled that of WT at E14.5,
E15.5, and E16.5, respectively (Figures 2C–2J).
Consistent with that, quantification revealed a deficit of APs in
the MZ of Zeb1/ embryos until E17.5 (Figures 2M and 2N).
However, from E14.5, numbers of APs in themutant MZ progres-
sively increased similarly to WT, albeit with a 24-hr delay, and1474 Cell Reports 17, 1473–1481, November 1, 2016eventually they reached a close to normal complement by
E18.5 (Figures 2K–2N). BrdU incorporation experiments per-
formed at E16.5 revealed that the proportion of migrating
Fgfr3+ APs that were also BrdU+ was comparable in both geno-
types (11.31% ± 2.38% in WT versus 10.38% ± 2.42% in
Zeb1/ mutants; Figures 2O and 2P), showing that mutant
APs proliferate normally on their migratory route. This suggested
that the delayed apparition and transient deficit of APs in the MZ
of Zeb1/mutants rather reflected a role for Zeb1 at early steps
of their development.
To characterize this defect, we first assessed cell proliferation
in the VZ at E13.5 by determining the proportion of Ki67+ cycling
progenitors that have incorporated BrdU during a 2-hr pulse. In
WT, divergences were observed along the DV axis (21.9% ±
2.45% dorsally versus 40.5% ± 4.9% ventrally), and no signifi-
cant differences were found in the mutants (22.6% ± 2.56%
dorsally versus 41.8% ± 4.6%ventrally; Figures 2Q and 2R), indi-
cating that, at this stage, VZ progenitors proliferate at a normal
rate in the absence of Zeb1. Next, extensive co-expression of
Zeb1 with Sox9 (Figures S1H–S1K) and apparent phenotypic
similarities between Zeb1/ and Sox9D/D mutants in which the
gliogenic switch is delayed by 24 hr (Stolt et al., 2003) prompted
us to test whether Zeb1 could influence similar processes. First,
analysis of Sox9 and NFIa expression in VZ progenitors of
Zeb1/ embryos revealed no difference compared to WT (Fig-
ures 2S–2X), though, at E13.5, there were reduced numbers of
Sox9+ cells in the mutant MZ and virtually all the remaining
ones were Olig2+ OPs (Figures 2W and 2X). This further illus-
trated that, whilemigrating OPswere detected on time in themu-
tants, APs were specifically affected. Second, we established
that loss of Sox9 function did not affect Zeb1 expression, thus
revealing no epistatic relationships between the two factors (Fig-
ures S1R and S1S). Third, we analyzed Aldh1l1, whose onset of
expression in the VZ is a good landmark of AP specification.
Indeed, Aldh1l1was induced at E12.5 in the ventralmost domain
of the VZ from which the first migrating APs arise 1 day later, and
it expanded dorsally at E13.5 (Figures 2Y and 2AA; Tien et al.,
2012). Analysis of Zeb1/ mutants revealed that, although at
E13.5 virtually no Aldh1l1+ AP was detected in the MZ, the
spatiotemporal profile ofAldh1l1 in the VZ appeared normal (Fig-
ures 2Z and 2AB), supporting the view that loss of Zeb1 function
does not perturb the timing of AP specification. In line with this,
analysis of spinal cord neuronal populations did not reveal any
significant changes in Zeb1/ animals (Figures S3A and S3B),
in contrast to Sox9D/D embryos (Stolt et al., 2003), indicating
that Zeb1 is dispensable for the gliogenic switch. We also
excluded a role for Zeb1 in early survival of APs (Figure S3C).
We finally determined that loss of Zeb1 function did not affect
the expression of patterning genes, including Nkx2-2, Nkx6-1,
or Pax6 (Figure S3D). Consistent with that, positional identity of
APs that exhibit complementary expression of Slit1 and Reelin
according to their origin along the DV axis (Hochstim et al.,
2008) was preserved in the mutants, albeit with a 24-hr delay
(Figure S3E).
Altogether, these data show that AP specification, prolifera-
tion, survival, and positional identity appear normal in Zeb1/
embryos, suggesting that delayed AP invasion into the mutant
MZ rather reflected impaired migration.
Figure 1. Zeb1 Expression in the Embryonic and Adult Spinal Cords
(A–D) Immunofluorescent staining for Zeb1 on thoracic spinal cord transverse sections of WT embryos at the indicated stages. Arrowheads in (B) and (C) point to
Zeb1+ MNs. Arrows in (C) point to Zeb1+ cells in the ventral MZ.
(E) Triple immunostaining for Zeb1 (red), Olig2 (green), and GFAP (blue) on E18.5 thoracic spinal cord transverse sections. The white dotted frame indicates the
position of close ups shown in (G) and (H).
(F) High-magnification image of E18.5 thoracic spinal cord transverse sections stained with Zeb1 and NeuN. Arrowhead points to Zeb1+/NeuN+ MNs.
(G and H) High-magnification images show E18.5 thoracic spinal cord transverse sections stained with Zeb1 and either Olig2 (G) or GFAP (H).
(I) Cultured astrocytes prepared at E18.5 were stained with Zeb1 and GFAP.
(J) Summary shows the dynamic expression profiles of Zeb1 and Zeb2 in the embryonic spinal cord during the neurogenic and gliogenic phases.
(K–O) Ventrolateral views show adult thoracic spinal cord transverse sections stained with Zeb1 and Sox10 (K), Olig2 (L), CC1 (M), AldoC (N), or GFAP (O).
Scale bars, 100 mm. See also Figure S1.
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Figure 2. Delayed Apparition of APs in the MZ of Zeb1/ Embryos
(A–L) In situ hybridization for Fgfr3 on thoracic spinal cord transverse sections from WT and Zeb1/ embryos between E13.5 and E18.5. Arrowheads point to
migrating streams of APs.
(M) Relative quantification of migrating APs in the MZ of WT and Zeb1/ embryos between E12.5 and E18.5 is shown.
(N) Numbers of migrating APs in the MZ of WT and Zeb1/ embryos from E12.5 to E18.5 are shown.
(O) Combined in situ hybridization for Fgfr3 (transformed in green pseudo-color) and immunostaining for BrdU (red) on thoracic spinal cord transverse sections at
E16.5 from WT and Zeb1/ mutants after a 2-hr pulse are shown.
(P) Quantification of the proportion of Fgfr3+ migrating APs that have incorporated BrdU after a 2-hr pulse at E16.5 in WT and Zeb1/ (/) embryos is shown.
(legend continued on next page)
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Onset of AP Emigration from the Spinal Cord VZ Is
Delayed in Zeb1/ Embryos
To assess AP migration, we took advantage of the singular
expression profile of the extracellular matrix glycoprotein TnC
(Karus et al., 2011). Indeed, in WT embryos, TnC was not de-
tected in the VZ at E12.5 (Figure S4A), but it was homogenously
induced at E13.5 except in the most ventral VZ domain, which
only exhibited scattered expression (Figures 3A and S4B).
Nevertheless, APs migrated out of this domain and TnC+ APs
were detected in the MZ adjacent to it (Figures 3A, S4B, and
S4C), showing that at ventral positions TnC is mainly induced
once APs have initiated their migration. In Zeb1/ embryos,
TnC was normally induced at E13.5, but, whereas no TnC+ AP
was found in the MZ at this stage, many TnC+ cells were
concomitantly observed in the ventral VZ domain abutting the
floor plate (Figure 3B), a phenotype still evident at E14.5 and
E15.5 (Figures 3C–3G). In addition, at E16.5, but not E17.5, clus-
ters of TnC+ cells were still abnormally detected in the dorsal VZ
domain of Zeb1/ embryos (Figures 3H–3K). These data show
that, in Zeb1/mutants, newly specified APs remain transiently
blocked in the VZ and start to migrate with a 24-hr delay.
Relatively little is known about the molecular determinants
controlling the onset of APmigration, although roles for TnC itself
(Karus et al., 2011) andApcdd1 (Kang et al., 2012) have been pro-
posed. However, analyses of both markers in Zeb1/ embryos
did not reveal any alteration of their expression (Figures 3A, 3B,
S4D, and S4E), suggesting alternative mechanisms. Zeb1 is a
major regulator of EMT, notably acting through direct repression
of the gene encoding the adhesion molecule Cadherin-1 (Cdh1;
Gheldof et al., 2012). Chromatin immunoprecipitation (ChIP)
assays performedonE13.5 spinal cords revealed that Zeb1 actu-
ally binds proximal regions of the Cdh1 promoter in vivo (Fig-
ure 3L), prompting us to assess its expression in the mutants.
In contrast toWT spinal cords in which Cdh1 expression was un-
der detectable thresholds at all stages analyzed, in Zeb1/ em-
bryos Cdh1 was ectopically detected in the VZ, first ventrally at
E12.5, then in more dorsal regions until E16.5 (Figure 3M). This
result is strikingly reminiscent of the deregulation of Cdh1 previ-
ously described in several brain regions of Zeb1/ mutants at
late embryonic stages (Liu et al., 2008). In many tissues and can-
cer cells, the presence of Cdh1 is incompatible with a migratory
phenotype (Gheldof andBerx, 2013). In linewith this, ex ovo elec-
troporation of E6 chick spinal cords that were cultured as
explants for 48 hr showed that Cdh1-transfected cells had a
significantly higher tendency to remain in the VZ compared to
cells transfected with a control vector (Figures 3N–3P). Thus,
transient derepression of Cdh1 may provide one mechanism by(Q) Double-immunofluorescent staining for Ki67 and BrdU on thoracic spinal co
embryos after a 2-hr pulse of BrdU is shown.
(R) Quantification of the proportion of Ki67+/BrdU+ cells over the Ki67+ population
of BrdU at E13.5 in WT and Zeb1/ embryos is shown.
(S–V) Immunofluorescent staining for Sox9 (S and T) and NFIa (U and V) on thora
shown.
(W and X) Ventrolateral views of thoracic spinal cord transverse sections from
Arrowheads point to Sox9+/Olig2+ OPs that are present in both genotypes, whil
(Y–AB) In situ hybridization for Aldh1L1 on thoracic spinal cord transverse sectio
Arrowhead in (AA) points toward migrating APs in the ventral MZ.
Scale bars, 100 mm. In (M), (N), (P), and (R), data are represented as mean ± SEMwhich the onset of AP emigration is impaired inZeb1/mutants.
It is of note that levels of ectopicCdh1were lower compared to its
endogenous expression sites (insets in Figure 3M) and that no
Cdh1+ cells were observed in the MZ when mutant APs eventu-
ally delaminated (Figure 3M), suggesting that other determinants
act in parallel to Zeb1 to finally repress Cdh1.
Interestingly, these findings illustrate some similarities be-
tween the processes of AP delamination from the VZ and EMT,
and they are highly reminiscent of the impaired migration of neu-
ral crest cells consequent to Zeb2 knockdown, reflecting dereg-
ulation of Cdh1 in the dorsal neural tube at early stages (Van de
Putte et al., 2003; Rogers et al., 2013). They are also strikingly
evocative of the function of Scratch1/2 transcription factors in
controlling the onset of cortical neuron precursor migration
through repression of Cdh1 (Itoh et al., 2013). To a lesser extent,
they recall the role of Foxp2/4 proteins in repressing Cdh2 in
young spinal cord neurons, thus allowing their detachment
from the VZ (Rousso et al., 2012), though we did not observe
obvious alteration of Cdh2 expression in Zeb1/ mutants (Fig-
ures S4F and S4G). Altogether, these data show that fine regula-
tion of cell-adhesive properties appears as a widespread
process involving multiple families of transcriptional regulators
at distinct stages and locations throughout the developing ner-
vous system, which influences neural precursor migration.
Intriguingly, in contrast to APs, OP migration occurred on time
in Zeb1/ mutants. This may reflect that OPs start to migrate
earlier than APs, at around E12.5 (Figures S2R and S2S; Touahri
et al., 2012). At that time, there was no deregulation of Cdh1 in
the mutant Olig2+ domain (Figures S2T and S2U), and Zeb2
expression was still ongoing in the VZ, albeit at low levels (Fig-
ure S1C). In the same line, no obvious defect was observed dur-
ing the earlier neurogenic phase in Zeb1/ embryos. During this
period, Zeb2 was expressed in the VZ and Zeb1 was only de-
tected at low levels (Figures 1A and S1A–S1C). Thus, although
roles for Zeb1 during neurogenesis and oligodendrogenesis
cannot be totally ruled out, the dynamic spatiotemporal profile
and levels of Zeb proteins combined with possible functional re-
dundancies may account for the apparent specific requirement
of Zeb1 in APs.
Early Defects of AP Migration or Specification Later
Perturb Their Differentiation
At spinal levels, induction of the GFAP protein is a classic indica-
tor of the differentiation of AP subtypes, starting at around E16.5
when cells have reached the pial surface of the spinal cord (Row-
itch and Kriegstein, 2010; Hong and Song, 2014). At this stage,
analysis of Zeb1/ embryos revealed that fewer APs had settledrd transverse sections at E13.5 from WT (left panel) and Zeb1/ (right panel)
in dorsal (left graph) and ventral (right graph) regions of the VZ after a 2-hr pulse
cic spinal cord transverse sections from WT and Zeb1/ embryos at E12.5 is
WT and Zeb1/ embryos at E13.5 stained with Sox9 and Olig2 antibodies.
e arrows point to Sox9+/Olig2 APs that are only detected in WT.
ns from WT and Zeb1/ mutants at E12.5 (Y and Z) and E13.5 (AA and AB).
(**p < 0.01 and ***p < 0.001). See also Figures S1–S3.
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Figure 3. Zeb1 Controls the Onset of AP Emigration from the VZ
(A–F) Double in situ hybridization for Shh (red) and TnC (transformed in green pseudo-color) on thoracic spinal cord transverse sections of WT and Zeb1/
mutants at E13.5 (A and B), E14.5 (C and D), and E15.5 (E and F). Brackets delineate the ventral VZ domain abutting the Shh+ floor plate.
(G) Quantification of TnC+ cells in the ventral VZ domain of WT and Zeb1/ embryos at E14.5 is shown.
(H–K) In situ hybridization for TnC on thoracic spinal cord transverse sections fromWT and Zeb1/ embryos at E16.5 (H and I) and E17.5 (J and K). Arrowheads in
(I) point to dorsal groups of TnC+ in the dorsal VZ of the mutants at E16.5. Red dotted lines delineate the central canal.
(L) qPCR from ChIP assays performed on E13.5 spinal cords with a Zeb1 antibody (Ab) or control IgG, using primers flanking Zeb1-binding sites in the Cdh1
promoter, or located in the Myoglobin gene as a negative control. Data are represented as percentage of input DNA.
(M) Representative images of the VZ of WT and Zeb1/ embryos stained for Cdh1 at the indicated stages. Note that levels of ectopic Cdh1 expression in the
mutant are lower than in its endogenous sites, as shown in kidney tubules (insets in right panels).
(N and O) Transverse sections of chick spinal cord explants cultured for 48 hr after electroporation at E6 of expression vectors either containing a truncated form
of the Cdh1 cDNA (N, pcDNA3-DCdh1) or the full-length Cdh1 cDNA (O, pcDNA3-Cdh1), stained by in situ hybridization with a probe recognizing both mRNAs.
Red dotted lines delimit the VZ and MZ.
(P) Spatial distribution of cells expressing either DCdh1 or Cdh1 in the VZ (left graph) and in the MZ (right graph) is shown.
Data are represented as mean ± SEM (**p < 0.01 and *p < 0.005). Scale bars, 100 mm. See also Figures S2 and S4.at the margin of the spinal cord compared toWT (Figures 4A and
4B), consistent with the fact that they leave the VZ in a delayed
manner. Strikingly, in parallel we found that GFAP expression
was reduced in the mutant white matter compared to WT and
was not concomitantly ectopically detected in the gray matter
(Figures 4D and 4E). This suggested that early delay of APmigra-
tion later perturbs the timing of their differentiation.
To further test this issue, we analyzed Sox9D/D mutants in
which glial cell specification and, in turn, migration were delayed
by 24 hr. In agreement with previous findings (Stolt et al., 2003),
we observed that at E16.5 fewer APs had invaded the mutant1478 Cell Reports 17, 1473–1481, November 1, 2016white matter (Figure 4C), and we found that GFAP expression
also was reduced at this stage (Figure 4F), thus echoing the
Zeb1/ mutant phenotype. By E18.5, however, robust expres-
sion of GFAPwas observed ventrally in Zeb1/ embryos (arrow-
heads in Figures 4G and 4H), which correlated with the presence
of numerous Fgfr3+/Slit1+APs in the ventral whitematter (arrow-
heads in Figures 4I–4L). At more dorsal positions, however,
levels of GFAP were still slightly reduced compared to WT
(brackets in Figures 4G and 4H), correlating with fewer Fgfr3+/
Reelin+ cells located at the margin of the mutant spinal cord
compared to WT (brackets in Figures 4I, 4J, 4M, and 4N). These
Figure 4. Delayed Induction of GFAP in
Zeb1/ and Sox9D/D Mutants Correlates
with Mis-positioning of APs in the White
Matter
(A–C) Ventrolateral views show E16.5 thoracic
spinal cord transverse sections fromWT, Zeb1/,
and Sox9D/D embryos stained by in situ hybridi-
zation with an Fgfr3 probe.
(D–F) Immunofluorescent staining for GFAP on
thoracic spinal cord transverse sections from WT,
Zeb1/, and Sox9D/D embryos is shown.
(G–N) Ventrolateral views of E18.5 thoracic spinal
cord transverse sections from WT and Zeb1/
embryos, showing GFAP (G and H), Fgfr3 (I and J),
Slit1 (K and L), and Reelin (M and N) expression.
Arrowheads point to the ventral white matter ex-
hibiting a high level of GFAP expression in both
genotypes, which correlates with the presence of
numerous Fgfr3+ and Slit1+ APs. Brackets point to
reduced GFAP expression at more dorsal posi-
tions in the mutants compared to WT, correlating
with reduced numbers of Fgfr3+ and Reelin+ APs
at the margin of the mutant spinal cord. Scale
bars, 100 mm.results thus show that early defects of AP migration or specifica-
tion, respectively, in Zeb1/ and Sox9D/D mutants are later
associated with delayed invasion of the white matter by APs
and postponed induction of GFAP. These data further support
the notion that duration of AP exposure to environmental cues
and/or their correct positioning influence the timing of their differ-
entiation (Barnabe´-Heider et al., 2005; Hong and Song, 2014).
It is of note that the embryonic lethality of Zeb1-deficient mice
precluded full assessment of glial cell differentiation that largely
proceeds at post-natal stages. Moreover, the fact that at adult-
hood Zeb1 is specifically maintained in mature astrocytes and
adult OPs, which both retain some precursor-like properties and
migratorycapacities, leavesopen thepossibility that this transcrip-
tional regulator also may influence adult gliogenesis. Conditional
knockdownapproacheswill certainlyhelp toaddress these issues.EXPERIMENTAL PROCEDURES
Mouse Strains
Procedures involving animals and their care were conducted according to the
French Ministry of Agriculture and the European Community Council Directive
no. 86/609/EEC, OJL 358. Protocols were validated by the Direction De´parte-Cell Repomentale des Services Ve´te´rinaires de l’He´rault
(Certificate of Animal Experimentation no. 34-
376). Zeb1/ and Sox9D/D embryos were ob-
tained and genotyped as previously described
(Takagi et al., 1998; Stolt et al., 2003).
Astrocyte Culture
Astrocytes were prepared from E18 WT embryos
as previously described (Perraud et al., 1990).
Histological Analyses
Simple or double in situ hybridization and immuno-
fluorescentstainingoncryosectionswereperformed
as previously described (Vente´o et al., 2012). Anti-sense RNA probes for Aldh1L1, Apcdd1, Chx10, Fgfr3, Gata3, Lbx1,
Nkx2-2, Nkx6-1, Pax6, PdgfRa, PLP1, Reelin, Sim1, Slit1, Shh, Sox10, Tlx3,
and TnC were used. Antibodies used in this study were as follows: goat
AldoC (Santa Cruz Biotechnology), mouse APC (clone CC1; Calbiochem),
rat BrdU (Abcam), rat Cadherin-1 (Alexis Biochemicals), rabbit Cadherin-2
(Abcam), rabbit and mouse GFAP (Dako), rabbit Ki67 (Abcam), mouse
NeuN (Millipore), rabbit NFIa (Active Motif), goat Olig2 (Santa Cruz Biotech-
nology), goat Sox2 (Abcam), rabbit Sox9 (Stolt et al., 2003), guinea pig
Sox10 (gift of M. Wegner), rabbit Zeb1 (Darling et al., 2003), and rabbit
Zeb2 (Santa Cruz Biotechnology). Alexa Fluor 594-, 488-, or 647-conjugated
secondary antibodies (Thermo Fisher Scientific) were used. Apoptosis was
assessed using the ApopTag peroxidase detection kit (Millipore). For prolifer-
ation assays, BrdU (Sigma) was injected intraperitoneally into pregnant mice
(2 mg/animal) at E13.5 or E16.5, 2 hr before sacrifice. For BrdU detection,
slides were incubated in 10 mM sodium citrate buffer (pH 6.0) at 95C
for 15 min, then at room temperature (RT) for 15 min, and subjected to
immunostaining. For double Fgfr3/BrdU experiments, Fgfr3 in situ hybridiza-
tion was performed first.
ChIP
ChIP assay was performed as previously described (Ne`gre et al., 2006) on 30
E13.5 WT spinal cords dissected clear of surrounding tissues. Rabbit-poly-
clonal antiserum for ZEB1 (H-102, Santa Cruz Biotechnology) and control rab-
bit IgG (sc-2027, Santa Cruz Biotechnology) were used. Promoter occupancy
was assessed by quantitative real-time PCR using primers in the Cadherin-1rts 17, 1473–1481, November 1, 2016 1479
promoter (forward: 50-AGACAGGGGTGGAGGAAGTT-30; reverse: 50-GGGC
AGGAGTCTAGCAGAAG-30) or the Myoglobin gene as control. For each con-
dition, two biological and two technical replicates were performed.
Chick Electroporation
This was performed as previously described (Touahri et al., 2012) using a
pcDNA3-Cdh1 expression vector (gift of P. Cossart) or a truncated form of
the same vector (pcDNA3-DCdh1).
Cell Counts
Quantification in mice was carried out on three independent embryos of each
genotype. For chick experiments, two independent experiments were per-
formed and sections from four explants for each condition were analyzed.
Cell counts were performed using the ImageJ software.
Statistical Analyses
Quantitative analyses were statistically analyzed using Student’s t test and
represented as mean ± SEM.
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